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Imperatoxin A (IpTxa) is known to modify the gating of skeletal ryanodine receptor (RyR1). In this paper, the ability of charged
aa residues of IpTxa to induce substate of native RyR1 in HSR was examined. Our results show that the basic residues (e.g., Lys19,
Lys20,L y s 22,A r g 23, and Arg24) are important for producing substate of RyR1. In addition, other basic residues (e.g., Lys30,A r g 31,
and Arg33) near the C-terminus and some acidic residues (e.g., Glu29,A s p 13, and Asp2) are also involved in the generation of
substate. Residues such as Lys8 and Thr26 may be involved in the self-regulation of substate of RyR1, since alanine substitution of
the aa residues led to a drastic conversion to the substate. The modiﬁcations of the channel gating by the wild-type and mutant
toxins were similar in puriﬁed RyR1. Taken together, the speciﬁc charge distributions on the surface of IpTxa are essential for
regulation of the channel gating of RyR1.
1.Introduction
In striated muscles, depolarization of the cell surface mem-
branes leads to activation of ryanodine receptors (RyRs) in
the junctional sarcoplasmic reticulum (SR) [1–5]. A number
of endogenous RyR modulators such as calmodulin, FK506-
binding proteins, calsequestrin, triadin, and HRC have been
identiﬁed [6–8]. Exogenous modulators of RyRs such as
toxins and peptides have also been reported [9, 10].
Imperatoxin A (IpTxa) from the African scorpion Pand-
inus imperator is a high-aﬃnity modulator of skeletal
RyR (RyR1). It greatly increases open probability (Po)a n d
[3H]ryanodine binding to RyR1 at nanomolar concentration
[11, 12]. Moreover, binding of IpTxa to RyRs reconstituted
in planar lipid bilayers generates marked occurrence of
long-lasting openings in subconductance state (substate)
[13]. Confocal imaging of skeletal muscle ﬁbers to monitor
IpTxa-induced Ca2+ sparks demonstrate that the toxin
induces long-duration and low-amplitude local Ca2+ release
consistent with the observation of the prolonged substate
in the presence of IpTxa [14]. Another structurally related
scorpion toxin, maurocalcine (MCa), and one speciﬁc small
fragment of II-III loop region of skeletal DHPR (Peptide A)
also bind to RyR1 and modify channel activity [15–18]. MCa
also strongly enhances [3H]ryanodine binding to RyR1 and
induces long-lasting substate with the current amplitude of
48%ofthefullconductance[16,18].PeptideAcouldbindto
RyR1andcouldeitheractivateorinhibittheactivityofRyR1.
It could also induce the long-lasing substate [15, 17, 19].
A comparison of the amino acid (aa) sequences of these
RyR1-modiﬁng probes shows a common basic aa domain
and the C-terminal hydroxyl-containing side chain. The aa
sequences may also contribute to the essential structure for
activating RyR1 [15, 16]. Especially, a cluster of positively
charged aa residues on the surface of the peptide A is critical
for activation of RyR1 [19, 20]. The mutations of the speciﬁc
basic residues of MCa and IpTxa have failed to induce long-
lasting substate and to potentiate [3H]ryanodine binding
[20, 21]. To date, the ability of a single aa residue of IpTxa to
controlthesubstateofRyR1isnotfullyunderstood.Recently
we have found that several basic aa residues of IpTxa (e.g.,
Lys19,A r g 23,a n dA r g 33) are necessary for increasing open
probability and inducing substate in rabbit skeletal RyR1
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In the present study, to evaluate the roles of the charged
aa residues of IpTxa in modifying the RyR1 gating, synthetic
wild-typeandalanine-scanningmutantsofIpTxa weretested
on planar lipid bilayer-incorporated RyR1. The basic aa
mutants(e.g.,K19A,K20A,K22A,R23A,andR24A)resulted
in a signiﬁcant loss of production of substate in RyR1,
consistent with the previous suggestion that the critical
basic domain of toxin determines its binding to the channel
[15, 16, 22]. The eﬀective domain encompassing these basic
residues involved in producing substate is structurally con-
servedwithbothMCaandPeptideA[19,23].Thissuggestsa
commonroleofthehighlyclusteredpositivechargesfortheir
actiononRyR1channelgating.Themutationsofsomeacidic
residues (e.g., Asp2,A s p 13,a n dG l u 29) and basic residues
within C-terminal region of IpTxa (e.g., Lys30,A r g 31,a n d
Arg33)alsoledtoasigniﬁcantinhibitiononthegating.When
Lys8 and Thr26 were replaced by alanine, the substate was
predominant indicating that these two residues are essential
for the functions of the toxin. In addition, the eﬀects of the
wild-type and mutant toxins on the gating behavior of RyR1
are strikingly similar when the native RyR1 in SR and the
puriﬁed RyR1 are used for the incorporation into bilayers,
suggesting that generation of the substate is due to a direct
binding of the toxin to RyR1.
2.MaterialsandMethods
2.1. Materials. Porcine brain phosphatidylethanolamine and
phosphatidylserinewerepurchasedfromAvantiPolarLipids,
I n c .A l lo t h e rr e a g e n t sw e r ef r o mS i g m a .
2.2. Chemical Synthesis of Wild-Type and Mutant IpTxa
Peptides. The peptide synthesis was conducted by a peptide
synthesizer (Applied Biosystems model 433A). The linear
precursors of wild-type and mutant IpTxa were synthe-
sized by solid-phase Fmoc chemistry starting from Fmoc-
Arg (2,2,5,7,8-pentamethylchroman-6-sulphonyl)-Alko or
Fmoc-Ala-Alko resin using a variety of blocking groups for
amino acid protection. After cleavage by triﬂuoroacetic acid,
crude linear peptides were extracted with 2M ethanoic acid,
diluted to ﬁnal peptide concentration of 25μMi nas o l u t i o n
of 1M ammonium acetate and 2.5mM reduced/0.25mM
oxidized glutathione adjusted to pH 7.8 with aqueous
NH4OH, and stirred slowly at 4◦C for 2-3 days. In the
redox buﬀer system, oxidized glutathione acts as oxidase and
assists in the formation of disulﬁde bonds whereas reduced
glutathione functions as disulﬁde isomerase and facilitates
formation of correct disulﬁde bonds by promoting rapid
reshuﬄing of incorrect disulﬁde parings. A 10:1 mixture
of reduced and oxidized glutathione was suggested to be
an eﬃcient redox buﬀer system for producing disulﬁde
bonds in IpTxa [21]. The folding reactions were monitored
by HPLC. The crude oxidized products were puriﬁed by
successive chromatography with CM-cellulose CM-52 and
preparative HPLC with C18 silica columns. The purity of all
analogues were in the range of 60 to 95% as measured by
analyticalHPLCandMALDI-TOF-MS(matrix-assistedlaser
desorptionionization-time-of-ﬂightMS)measurements(see
Supplementary Figure 1 (in Supplementary material avail-
able online at doi: 10.1155/2011/386384)).
2.3. Preparation of Junctional SR Vesicles from Rabbit Skeletal
Muscle. A heavy fraction of fragmented SR vesicles (HSR)
containing junctional SR was prepared from rabbit fast-
twitch back and leg muscles as described previously [24].
2.4. Planar Lipid Bilayers. Single-channel recordings of rab-
bit skeletal RyR1 incorporated into planar lipid bilayers
w e r ec a r r i e do u ta sd e s c r i b e dp r e v i o u s l y[ 25–27]. Lipid
bilayers,consistingofbraintissuephosphatidylethanolamine
and phosphatidylserine (1:1) in decane (20mg/mL) were
formed across a hole of approximately 200μm diameter.
Thinning of the bilayer was monitored by bilayer capac-
itance. The basic composition of the cis/trans solution
consisted of 300mM cesium methanesulfonate, 10mM
Tris/Hepes (pH 7.2), 2mM EGTA, and 1.998mM CaCl2
([Ca2+]free = 10μM) [27]. [Ca2+]free was calculated using
the “Chelator” program (Theo Schoenmaker). Cs+ was
selected as the charge carrier to ensure precise control of
free [Ca2+], to increase the channel conductance, and to
avoid any contribution from potassium channels present in
the SR membrane [12]. Chloride channels were inhibited
by using the impermeant anion methanesulfonate [12].
Incorporation of ion channels was carried out as described
by Miller and Racker [25] and conﬁrmed by recording
the characteristically high single-channel conductance of
RyRs [27, 28]. The trans side was maintained at ground
and the cis side was clamped at −30mV relative to the
ground. After addition of the IpTxa to the cis chamber, the
single channel data were collected at −30mV for 2–5min.
The channel activity was recorded on a DTR-1204 Digital
Recorder (Biologic Science Instrument) and displayed on a
Tektronix TDS 340A oscilloscope. Recordings were ﬁltered
with an 8-pole low-pass Bessel ﬁlter at 1kHz and digitalized
throughaDigidata 1200seriesinterface(AxonInstruments).
Data acquisition and analysis were done with the Axon
Instruments software, pClamp v7.0.
Data were analyzed using the Hill equation described
previously [12, 13, 15]:
Psubstate =

Psubstate, max


1+

EC50/

IpTxa
nH or
Po =

Po, max


1+

EC50/

IpTxa
nH,
(1)
where (Po,m a x) is the Po observed at saturating concentra-
tions of IpTxa,E C 50 is the IpTxa concentration for which
50% of Po,max is obtained and nH is the Hill coeﬃcient.
Also, Psubstate, max is the Psubstate observed at saturating
concentrations of IpTxa,E C 50 is the IpTxa concentration for
which 50% of Psubstate, max is obtained, and nH is the Hill
coeﬃcient. The probability of full open state of the channel
(Po) was deﬁned as the ratio of the time spent in the open
state to the total time exclusive of time spent in the substate.
The probability to obtain substate (Psubstate) was calculatedJournal of Biomedicine and Biotechnology 3
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Figure 1: Properties of single channel gating in IpTxa-modiﬁed native RyR1. (a) Channel current traces of a single skeletal RyR1 in planar
lipid bilayers activated by various concentrations of IpTxa. IpTxa at 6–100nM (ﬁnal) was added to the cis solution to activate the channel.
Channel openings are shown as downward deﬂections. Channel activities were recorded at a holding potential of −30mV. (b) A plot of Po
versus concentration of IpTxa to activate rabbit skeletal RyR1. Data points are means ± SE of ten experiments. (c) A plot of Psubstate versus
IpTxa concentration for rabbit skeletal RyR1. Data points are means ± SE of 9 experiments.
as the time spent in the substate divided by a given total
recording time. The durations of the substate were obtained
by manual positioning of the cursors and constructing all
point histograms. Mean duration of substate was measured
by total substate time divided by total substate frequencies.
2.5. Statistical Analysis. Results are given as means ± SE.
Signiﬁcant diﬀerences were analyzed using Student’s t-test.
Diﬀerences were considered to be signiﬁcant when P<0.05.
The ﬁtting of the data to the graphs were carried out using
the software, Origin v7.
3. Results
3.1. Eﬀects of IpTxa on Single-Channel Gating Properties of
RyR1. To examine how IpTxa modiﬁes RyR1 activity, RyR1
in HSR incorporated in planar lipid bilayers was tested
in the presence or absence of synthetic wild-type IpTxa.
The chamber solutions for both cis (cytosolic) and trans
(luminal) sides included 300mM cesium methanesulfonate
and 10mM Tris-Hepes (pH 7.2). 10μMf r e eC a 2+ was added
to the cis side to activate the incorporated RyR1. After an
addition of IpTxa to the cis chamber, the single channel
gating properties were recorded at a holding potential
of −30mV for over 2min at each toxin concentration.
Figure 1(a) shows traces from continuous recordings in
the absence and in the presence of 6, 15, 30, 50, and
100nM IpTxa. When the toxin concentration increased, the
occurrence of substate of RyR1 was remarkably increased. To
examine the eﬀects of IpTxa on full open state, we calculated
the probability to obtain the full open state (Po) as the time
spent in the open state divided by the total time exclusive4 Journal of Biomedicine and Biotechnology
of the time spent in the substate. The time for recorded Po
was in the range of 30s–2min. Figure 1(b) shows a plot of Po
versus IpTxa concentration at 10μMC a 2+. The steady-state
Po was0.18 ±0.02at10μMCa 2+.Whentheconcentrationof
IpTxa was increased in cischamber, Po increased markedly to
0.7, suggesting that the cytosolic IpTxa enhanced the channel
activity by increasing open probability in a dose-dependent
manner. Using the Hill equation (1) the parameters such
as Po,max,E C 50,a n dH i l lc o e ﬃcient (nH) were calculated.
The calculated Po,max and EC50 for Po were 0.72 ± 0.02 and
17.35 ± 4.67nM, respectively. The Hill coeﬃcient (nH) for
Po was 1.14. Application of IpTxa to the trans (SR lumen)
side of chamber did not show any eﬀect (data not shown),
suggesting that increase of the full opening events of the
RyR1 channel is due to interaction between the toxin and the
cytosolic region of the channel.
In light of the evidence that IpTxa could induce substate
bothincardiacandskeletalRyRs[13],theeﬀectsofsynthetic
IpTxa on the occurrence of substate were tested using native
RyR1 in rabbit skeletal HSR. Figure 1(a) shows that an
additionofIpTxa tothecissideofRyR1channelcouldinduce
the substate. The probability to obtain substate (Psubstate)
increased, when the concentration of IpTxa increased from
6 to 100nM in the cis chamber (Figure 1(c)). The calculated
Psubstate, max and EC50 for Psubstate were 0.92 ± 0.06 and 23.27
± 2.37nM, respectively. The Hill coeﬃcient (nH) for Psubstate
was 1.24, suggesting that IpTxa and RyR1 do not have the
cooperative bindings in the concentration range.
3.2. Eﬀects of Alanine Scanning Mutants of IpTxa on RyR1.
In the previous studies [21, 22], it was proposed that
speciﬁc basic amino acid residues on the surface of IpTxa
are required for the electrostatic interaction of the toxin
with RyR1. Particularly, Gurrola et al. [15] suggested the
structural domain composed of Lys19-Arg24 followed by
Thr26 is responsible for the IpTxa-RyR1 binding. A possible
molecular interaction between IpTxa and RyR1 was further
investigated in the present study by producing various
alanine scanning mutants at charged aa. We ﬁrst tested the
eﬀects of IpTxa mutants on substate of RyR1 at a holding
potential of –30mV.
ThesinglechanneltracesofRyR1activatedat30nMwild
type or mutant IpTxa are shown in Figure 2(a).A b i l i t yo f
the diﬀerent mutant toxins to induce substate of RyR1was
further tested using diﬀerent toxin concentrations. Interest-
ingly, both K8A and T26A mutants displayed a signiﬁcantly
increased substate lifetime, indicating a negative role of these
residues in modifying RyR1 gating. Psubstae, max of K8A or
T26A reached almost to 1, and EC50 (nM) values were
shifted from 23.27 ± 0.37 (wild type) to 5.70 ± 2.86 (K8A)
or to 9.98 ± 1.92 (T26A; Figure 2(b) and Table 1). The
mutations of the basic aa (Lys19,L y s 20,L y s 22,A r g 23,A r g 24,
Lys30,A r g 31,a n dA r g 33) signiﬁcantly reduced the probability
to obtain substate (Psubstate), compared with the wild-type
toxin (Figure 2(b) and Table 1). The eﬀect of D15A mutant
was similar to that of wild-type toxin, suggesting no major
involvement of Asp15 in the binding between the toxin and
RyR1. On the other hand, the substitutions of some acidic aa
Table 1: Eﬀects of the mutant IpTxa on Psubstate of native RyR1 in
SR. Psubstate, max and EC50 for Psubstate, max were calculated using (1)a s
describedin“Section 2.”Valuesaremeans ±SEof3–9experiments.
Theaveragelengthsofthesubstateeventsweredeterminedat30nM
concentration. Asterisks indicate signiﬁcant diﬀerences from the
wild-type toxin for each parameter (Student t-test, P<0.05). ND:
not determined.
Psubstate Mean duration
of substate (s) Psubstate, max EC50 (nM)
Wild type 0.92 ± 0.06 23.27 ± 2.37 4.56 ± 0.42
K8A 0.97 ± 0.01 5.70 ± 2.86∗ ND
T26A 0.98 ± 0.05 9.98 ± 1.92∗ 3.66 ± 0.40∗
D15A 0.91 ± 0.05 21.47 ± 1.92 4.50 ± 0.51
R9A 0.75 ± 0.05∗ 19.91 ± 3.16 5.86 ± 0.52∗
K11A 0.70 ± 0.07∗ 21.76 ± 3.49 4.35 ± 1.07
D13A 0.62 ± 0.07∗ 21.72 ± 7.92 2.76 ± 0.25∗
K19A 0.43 ± 0.07∗ 21.84 ± 6.47 1.94 ± 0.43∗
R31A 0.40 ± 0.03∗ 19.24 ± 4.65 3.42 ± 0.27∗
D2A 0.38 ± 0.08∗ 28.63 ± 14.02 2.96 ± 0.60∗
R23A 0.32 ± 0.09∗ 19.54 ± 9.36 2.50 ± 0.26∗
R24A 0.26 ± 0.08∗ 26.03 ± 7.01 1.55 ± 0.94∗
E29A 0.19 ± 0.03∗ 6.07 ± 4.28∗ 1.75 ± 0.29∗
K30A 0.19 ± 0.02∗ 16.66 ± 2.86∗ 1.72 ± 0.39∗
K20A 0.18 ± 0.05∗ 18.53 ± 8.17 3.64 ± 0.78∗
R33A 0.14 ± 0.03∗ 16.03 ± 5.65∗ 1.97 ± 0.19∗
K22A 0.12 ± 0.02∗ 18.49 ± 2.88 3.31 ± 0.15∗
suchasAsp2,Asp 13,andGlu 29 byalaninealtertheprobability
to obtain substate signiﬁcantly (Figure 2 and Table 1). These
results suggest that the charged aa distributed on the surface
ofIpTxa contributetothestimulatoryactionofthetoxinand
to the interaction between IpTxa and RyR1.
3.3. Mean Duration of IpTxa-Induced Substate. To investigate
the causes for the decreased Psubstate by the mutant toxins,
the average length of substate at 30nM wild type or mutant
of IpTxa was calculated as total substate time divided by
the toral frequencies of substate. The recording time in
each concentration was 2min. Despite the marked increase
in Psubstate as IpTxa was increased from 6nM to 100nM,
the mean duration of the IpTxa induced-substate of RyR1
appeared to be similar at diﬀerent [IpTxa]( Figure 4). The
average mean duration of substate of the mutants (D2A,
D13A, K19A, K22A, R23A, R24A, E29A, K30A, and R33A)
was signiﬁcantly less than that of wild-type IpTxa (Table 1).
Somemutants(K19A,R24A,E29A,andK30A)showedmore
m a r k e dr e d u c t i o ni nm e a nd u r a t i o no fs u b s t a t e( <2s).The
decreased mean duration of substate in the mutant toxins is
due probably to the loss of their ability to induce long-lasting
substate.
3.4. Eﬀects of IpTxa on Puriﬁed RyR1. To determine whether
the activation of native RyR1 in SR by IpTxa was due to a
direct activation of RyR1 or due to an indirect activation
through other proteins associated to RyR1, we added IpTxaJournal of Biomedicine and Biotechnology 5
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Figure 2: Single channel current traces of RyR1 modiﬁed by various alanine scanning IpTxa mutants. (a) Single channel current traces of
skeletal RyR1 activated in the presence of 30nM wild-type or various mutant IpTxa (cis side) at −30mV holding potential. Single channel
opening is shown as a downward deﬂection. (b) The plots of Psubstate of RyR1 versus concentration of IpTxa are shown. The data points are
means ± SE from 3–5 independent experiments.
to puriﬁed RyR1 incorporated into planar lipid bilayers
(Figure 3(a)). 30nM IpTxa increased Psubstate both in native
and puriﬁed RyR1 in a similar extent (Figures 1 and 3).
Figure 4 shows that the mean durations of substate of
puriﬁed RyR1 are similar to native RyR1 at the tested
concentration range, suggesting that the response of RyR1 to
IpTxa was not mediated by other RyR1-associated proteins.
Purity of RyR1 at the ﬁnal puriﬁcation step was veriﬁed by
Coomassie blue staining (Supplementary Figure 2).
3.5. Eﬀects of IpTxa Mutants on Puriﬁed RyR1. We further
tested the eﬀects of mutant IpTxa (K8A, K30A, R31A, or
R33A) on Psubstate of puriﬁed RyR1. Channel activity was
monitored for 2min in the presence of 6 to 100nM mutant
toxins (Figure 5(a)). The plots of Psubstate versus [IpTxa]
showed that the mutant toxins (K30A, R31A, and R33A) led
tomuchsmallerPsubstate (0.16 ±0.05,0.15 ±0.02,and0.18 ±
0.06,resp.)thanthatofwild-typeIpTxa(0.86±0.05)without
a signiﬁcant change of EC50 (Figure 5(b) and Table 2). K8A
led to similar Psubstate, max (0.85 ± 0.02) to wild-type toxin
(Figure 5(b)). K30A and R33A produced less than 2s of
mean duration of substate (Table 2).
4. Discussion
4.1. Eﬀects of IpTxa Mutants on Substate of RyR1. The
highly positive charges of the basic residues of IpTxa could
contribute to the formation of its functional surface area
having uniquely oriented charge distribution [15, 19, 21–
23]. In the present study we tested the hypothesis that
electrostatic force mediates the IpTxa-RyR1 interaction by
studyingtheeﬀectsofalaninescanningmutationsofcharged
aa residues in IpTxa on RyR1 functions.
Single point mutations of charged residues in IpTxa gen-
erally aﬀected the probability of occurring substate (Psubstate)
in RyR1 (Figure 2 and Table 1). Previously, it was shown
that mutations in a cluster of basic residues (Lys19-Arg24)
decreased the ability of the toxin to activate [3H]ryanodine
binding to RyR1 [15, 21]. The recombinant mutant toxins
(e.g., K19A, R23A, and R24A) were less eﬀective to increase
open probability (Po) and to induce substate of the channel
[22]. Our present results demonstrate that a cluster of the
basic residues 19–24 is necessary for inducing substate of
RyR1, conﬁrming the functional importance of the clustered
basic residues. In addition, replacing other basic residues
located in C-terminal region of IpTxa with alanine (e.g.,
K30A, R31A, and R33A) also reduced the eﬀects of the toxin
on channel modiﬁcation (Figure 2(b)). As described previ-
ously, the C-terminal basic residues (Lys22,A r g 23,a n dA r g 24)
are aligned in the central domain of IpTxa and possibly are
responsible for activating RyR1 [21]. Our present ﬁndings
agreewiththeprevioussuggestionthatthepositivelycharged
region within the C-terminus is involved in the interaction
with RyR1.Journal of Biomedicine and Biotechnology 7
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Figure 3: Eﬀects of IpTxa on puriﬁed rabbit RyR1 incorporated in planar lipid bilayers. (a) Single channel activity of puriﬁed RyR1
incorporated in planar lipid bilayers at 10μMC a 2+ with or without IpTxa (6–100nM) was recorded. Single channel currents are shown
as downward deﬂections from the closed level (indicated by c). The holding potential was −30mV. (b) The plot of Po of puriﬁed RyR1 versus
various concentrations of IpTxa is shown. (c) The plot of Psubstate of puriﬁed RyR1 versus various concentrations of IpTxa is shown. The
results are shown as the means ± SE for 7 experiments.
K8A and T26A, the two mutated analogs of IpTxa,
showed dramatically decreased EC50 of Psubstate compared to
that of wild-type toxin, indicating higher binding aﬃnity
to RyR1 (Figures 2(b) and 5(b)). Although the ability of
K8A to increase the substate lifetime of RyR1 was previously
studied using recombinant IpTxa mutant [22], the eﬀect of
K8A on [3H]ryanodine binding to RyR1 is controversial [15,
21]. T26A mutant was reported to reduce toxin-activated
ryanodine binding to RyR1 [15]. The inconsistency between
occurrence of substate and ryanodine binding to RyR1
aﬀected by K8A or T26A suggests multiple independent
actionsofIpTxa ondiﬀerentmodesofchannelgating.Infact,
Dulhunty et al. [17] proposed an existence of multiple toxin
binding sites within RyR1 including the transient activation
site and substate site [17].
4.2. The Eﬀects of IpTxa and Peptide A on RyR1 Gating.
Marked functional similarity of the three peptides, IpTxa,
MCa, and Peptide A has been proposed on the basis of their
primary structural homology of a speciﬁc domain consisting
of basic amino acids (Lys19-Arg23 of IpTxa or MCa, and
Arg681-Lys685 of Peptide A) [15, 17, 18, 23, 29]. Stretches
of these positively charged residues tend to adopt diﬀerent
secondary structures such as α-helical structure for Peptide
Aa n dβ-sheet structure for IpTxa and MCa. However,
their orientation on the surface of the peptides could be
similar [19, 21]. Peptide A was shown to share the common
binding site on RyR1 with IpTxa and MCa and mimicked
the toxin eﬀects on RyR1 gating [15, 23, 29]. However,
evidence for noncompetitive binding of MCa and peptide8 Journal of Biomedicine and Biotechnology
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Figure 4: Eﬀects of IpTxa on the mean durations of substate of
native and puriﬁed RyR1. Mean durations of the substate events in
native RyR1 versus puriﬁed RyR1 were determined in the presence
of6–100nMIpTxa.Datapointsaremeans ±SEfor10experiments.
A to RyR1 was shown by [3H]ryanodine binding and real-
time Surface Plasmon resonance (SPR) studies. MCa and
peptide A induced distinct modiﬁcation of channel gating
in an additive, but not competitive, manner. This indicates
the possibility of an existence of independent binding sites
for the two peptides on RyR1 [16]. These diﬀerent results
have been further understood by the hypothesis that the
toxins and peptide A binding sites within RyR have both
common activation site and independent substate sites [17].
Although the present results show that the mutations within
the structural motif shared by Peptide A inhibited substate
induction (Figure 2), it is hard to ﬁnd direct evidence of
competitive function in the common region of RyR1. Even
though our investigations were undertaken without Peptide
A, it could be suggested that the prolonged substate opening
triggered by IpTxa is independent of the action of Peptide
A[ 17]. Further study will be necessary to clarify whether
the structurally conserved domains of IpTxa and Peptide A
compete for the induction of substate in RyR1.
4.3. Comparison of the Active Sites with MCA. IpTxa and
MCa share 82% aa identity in their primary structures. In
addition to the similar β-sheet structure of the common
stretch of the basic residues (Lys19-Arg24), the solution struc-
tures of IpTxa and MCa exhibit similar overall molecular
folding [21, 30]. Because of this structural homology, these
two toxins share functional similarities. Both IpTxa and
MCa strongly induce SR Ca2+ release and activate ryanodine
binding to skeletal RyR. In addition, both peptides have the
ability to induce reversible transition of RyR1 gating mode
between substate and fast full open gating [12, 13, 15–17].
Previously, it was demonstrated that mutations of each basic
residue within Lys19-Thr26 and mutation of Lys8 of MCa
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Figure 5: Properties of single channel gating in wild-type and
mutant IpTxa-modiﬁed puriﬁed RyR1. (a) Single channel currents
of puriﬁed RyR1 activated in the presence of wild-type or mutant
IpTxa were measured at −30mV holding potential. The single
channelopeningisshownasadownwarddeﬂection.Therecordings
of single channel currents were measured at 30nM wild-type or
mutant IpTxa in the cis solution. (b) The plots of Psubstate of puriﬁed
RyR1 versus wild-type or mutant IpTxa at various concentrations.
decreased the ability of the toxin to induce Ca2+ release
and potentiate [3H]ryanodine binding in the SR [29]. More-
over, the occurrence of long-lasting substate was markedly
prevented by mutations of the basic residues within Lys20-
Arg24 of MCa [29]. This inhibitory eﬀect was reduced, if the
mutation was farther from Lys24 while alanine replacement
completely inhibited the substate event of skeletal RyR [17,
29]. Therefore, the previous results showing the eﬀects of
MCa mutants are partially coherent with our observations
of the eﬀects of IpTxa mutants on RyR1 substate. In theJournal of Biomedicine and Biotechnology 9
Table 2: Eﬀects of the mutant IpTxa on Psubstate of puriﬁed RyR1.
Psubstate, max and EC50 for Psubstate of puriﬁed RyR1 were calculated
as described in the legend to Table 1. Values are means ± SE of
4–10 experiments. The average lengths of the substate events were
determined at 30nM concentration. Asterisks indicate signiﬁcant
diﬀerences from the wild type for each parameter (Student t-test,
P<0.05). ND: not determined.
Psubstate Mean duration
of substate (s) Psubstate, max EC50 (nM)
Wild type 0.86 ± 0.05 17.08 ± 2.31 3.97 ± 0.18
K8A 0.85 ± 0.02 5.29 ± 4.84∗ ND
R33A 0.18 ± 0.06∗ 19.25 ± 1.05 1.43 ± 0.09∗
K30A 0.16 ± 0.05∗ 15.66 ± 5.99 1.88 ± 0.22∗
R31A 0.15 ± 0.02∗ 18.23 ± 1.65 3.15 ± 0.10∗
present study, IpTxa mutant, R24A, was the most eﬀective
in decreasing mean duration of substate of RyR1 (Figure 3
and Table 1). R24A mutant showed comparable Bmax value
of Psubstate with those of other mutants, R23A, K22A, and
K20A, although the values were signiﬁcantly less than that
of wild-type IpTxa (Figure 3 and Table 1). This suggests that
the common domain clustered by positively charged residues
(Lys20-Arg24) are responsible for the actions of two scorpion
toxins to induce long-lasting substate opening of skeletal
RyR1.
In spite of the high sequence identity, a signiﬁcant
functional diﬀerence between IpTxa and MCa has been
observed. Two toxins induced diﬀerent degree of substate
of RyR1 at +40mV holding potential (28% and 48% of
full conductance state for IpTxa and MCa, resp.) [10, 13].
In addition, comparison of 3D structures of two peptides
showed signiﬁcantly diﬀerent structural motifs near the N-
terminal regions, where MCa but not IpTxa has a β-strand
and makes the hydrophobic core by connecting to the side
chains of four cysteine residues, Cys10,C y s 16,C y s 21,a n d
Cys32 [21]. Thus, the diﬀerence in the functional eﬀect
between IpTxa and MCa on RyR1 gating appears to be
due to the subtle change in the local charge distribution
or a structural dissimilarity. Here we further suggest and
it appears that both acidic (e.g., Asp2,A s p 13,a n dG l u 29)
and basic residues of C-terminal region of IpTxa (e.g., Lys30,
Arg31,a n dA r g 33) are involved in functional interaction with
RyR1 in the case of IpTxa (Figure 2(b)). To our knowledge,
to date there is no report regarding to the involvement of the
acidic aa residues of IpTxa are related to the occurrence of
Psubstate of RyR1.
5. Conclusions
In this study, the ability of charged aa residues of IpTxa to
induce substate of RyR1 was examined in detail. Both basic
and acidic aa residues are involved in producing substate of
RyR1 supporting the hypothesis that the structural domain
constituting a local cluster of charged aa is important for
modifying the mode of channel gating [15, 16, 21]. Residues
such as Lys8 and Thr26 of IpTXa are important in terms
of their inhibitory role in producing substate of RyR1. The
modiﬁed channel gating properties induced by wild-type
and mutant toxins were found both in native and puriﬁed
RyR1.Takentogether,thespeciﬁcchargedistributionsonthe
surface of IpTxa may directly regulate the gating behavior of
RyR1.
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